Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Assets: 2023-2025

Historic Assets for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $86.4 million.

  • Camp4 Therapeutics' Assets rose 304.40% to $86.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.4 million, marking a year-over-year increase of 304.40%. This contributed to the annual value of $78.3 million for FY2024, which is 42.52% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' Assets stood at $86.4 million, which was up 68.49% from $51.3 million recorded in Q2 2025.
  • Camp4 Therapeutics' Assets' 5-year high stood at $86.4 million during Q3 2025, with a 5-year trough of $21.4 million in Q3 2024.
  • In the last 3 years, Camp4 Therapeutics' Assets had a median value of $58.9 million in 2023 and averaged $59.2 million.
  • Data for Camp4 Therapeutics' Assets shows a peak YoY soared of 304.40% (in 2025) over the last 5 years.
  • Camp4 Therapeutics' Assets (Quarterly) stood at $54.9 million in 2023, then spiked by 42.52% to $78.3 million in 2024, then surged by 304.40% to $86.4 million in 2025.
  • Its Assets stands at $86.4 million for Q3 2025, versus $51.3 million for Q2 2025 and $62.8 million for Q1 2025.